Propranolol efficacy in adolescent essential hypertension

Propranolol efficacy in adolescent essential hypertension

42 ABSTRACTS: HIGH BLOOD PRESSURE CONTROL A-19 DIFFICULTIES IN SCREENING AND RECRUITING FREE HYPERTENSIVE TREATMENT PROGRAM David M. Berkson, Er...

71KB Sizes 0 Downloads 61 Views

42

ABSTRACTS:

HIGH

BLOOD

PRESSURE

CONTROL

A-19 DIFFICULTIES IN SCREENING AND RECRUITING FREE HYPERTENSIVE TREATMENT PROGRAM David M. Berkson, Erich Brueschke, Jeanine Turner,

LOW INCOME

Heart Disease Control Officer, Murray C. Brown, Ghanim Kassir, Betty Allen, and Evelyn Stokes

COMMUNITY

RESIDENTS

INTO

A

Chicago Department of Health; Diane Mikes, Barbara Jalowiec,

As part of an ongoing totally free program to detect and treat all hypertensives in a low income black Chicago copunity, 2,417 (28.6%) of 8,461 persons screened during 1976 had blood pressure = 90 mm Hg and were invited back for a second blood pressure measurement. Only 1,045 (43%) elected to have the second determination performed by the screening team and the free program. Of 3,926 persons having repeat determinations in 1976, 2,135 (54.3%) had normal blood pressures. Of 1,791 invited for full evaluation and free treatment, only 960 (54%) elected to take advantage of this program while 814 (45%) elected other facilities for evaluation and treatment and 17 (1%) refused followup. In a three month period, Community Health Assistants made 615 separate home visits to 416 patients who had failed to show up for their second blood pressure determination, yet only 43 persons (0.72%) returned for the rescreening blood pressure. During the same period telephone calls and letters to 1,296 patients for the same purpose resulted in 55 persons (1.62%) reporting for repeat determinations. Although a high degree of success, greater than 80%, has been achieved in control of blood pressure of those entered into the treatment program,efforts at recruitment are disappointing. Further analysis of these problems will be presented.

A-20 PROPRANOLOL Pierre Montreal,

EFFICACY

IN ADOLESCENT

Biron, Department of Montreal, Canada:

ESSENTIAL

HYPERTENSION

Pharmacology, Faculty of Jean-Guy Mongeau, H8pital

Medicine, Ste-Justine,

A single-blind, crossover 8-month clinical trial of propranolol carried out in 10 adolescents with essential hypertension to cy of beta-blockade in this type of hypertension. Each blood from

treatment pressure 90 to 240

period lasted 4 months, and pulse measurements. mg daily.

University Montreal. versus determine

patients were seen at 2-week Maintenance dose of propranolol

of

placebo was the effica-

intervalsfor ranged

The mean systolic pressure was 144.5 after placebo, 120.00 mm Hg after propranolol, the difference of 24.5 being significant (p< 0.005) by paired t-test. The mean diastolic was 85.0 under placebo and 75.5 under propranolol, the difference of 9.5 mm Hg being significant (p < 0.05). Heart rate dropped from 82.8 per minute under placebo to 68 after propranolol, a significant (p< 0.001) difference of 14.8 b/ min. Side effects bradycardia therapy. Antihypertensive value under p< 0.05). It is concluded beta-blockade.

were minor and included and a transient Raynaud's

placebo Plasma

response for renin

that

was directly the diastolic, was unrelated

adolescents

with

transient fatigue phenomenon, none

after strenuous exercise, requiring cessation of

related (r = 0.93, and for the systolic to the response. essential

hypertension

p<

0.01) also (r

to the E 0.71,

respond

well

initial

to